Journal of the Association of Nurses in AIDS Care
Volume 21, Issue 3 , Pages 221-229 , May 2010

Providing Care to Transgender Persons: A Clinical Approach to Primary Care, Hormones, and HIV Management

References 

  1. Bockting W, Benner A, Coleman E. Gay and bisexual identity development among female-to-male transsexuals in North America: Emergence of a transgender sexuality. Archives of Sexual Behavior. 2009;38(5):688–701
  2. Centers for Disease Control and Prevention . Acute renal failure associated with cosmetic soft-tissue filler injections-North Carolina, 2007. Morbidity and Mortality Weekly Report. 2008;57(17):453–456Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5717a1.htm
  3. Chu JH, Gange SJ, Anastos K, Minkoff H, Cejtin H, Bacon M, et al. Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy. American Journal of Epidemiology. 2005;161(9):881–890
  4. Department of Health and Human Services. (2009). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Retrieved from http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
  5. De Sutter P. Reproductive options for transpeople: Recommendations for revision of the WPATH's Standards of Care. International Journal of Transgenderism. 2009;11(3):183–185
  6. Dizon DS, Tejada-Berges T, Koelliker S, Steinhoff M, Granai CO. Ovarian cancer associated with testosterone supplementation in a female-to-male transsexual patient. Gynecological and Obstetrical Investigation. 2006;62(4):226–228
  7. Dutton L, Koenig K, Fennie K. Gynecologic care of the female-to-male transgender man. Journal of Midwifery & Women's Health. 2008;53(4):331–337
  8. Feldman J. Medical and surgical management of the transgender patient: What the primary care clinician needs to know. In:  Makadon HJ,  Mayer KH,  Potter J,  Goldhammer H editor. Fenway guide to lesbian, gay, bisexual, and transgender health. Philadelphia, PA: Versa; 2008;p. 365–392
  9. Fenway Health. (2010). Transgender health. Retrieved from http://www.fenwayhealth.org/site/PageServer?pagename=FCHC_srv_services_trans
  10. Gaber Y. Secondary lymphoedema of the lower leg as an unusual side effect of a liquid silicone injection in the hips and buttocks. Dermatology. 2004;208(4):342–344
  11. Garofalo R, Deleon J, Osmer E, Doll M, Harper G. Overlooked, misunderstood and at-risk: Exploring the lives and HIV risk of ethnic minority male-to-female transgender youth. Journal of Adolescent Health. 2006;38(3):230–236
  12. Gay, Lesbian, and Straight Education Network. (2008). The 2007 National School Climate Survey: The experiences of lesbian, gay, bisexual, and transgender youth in our nation's schools. Retrieved from http://www.glsen.org/binary-data/GLSEN_ATTACHMENTS/file/000/001/1290-1.pdf
  13. Harder Y, Erni D, Banic A. Squamous cell carcinoma of the penile skin in a neovagina 20 years after male-to-female reassignment. British Journal of Plastic Surgery. 2002;55(5):449–451
  14. Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ, Spack NP, et al. Endocrine treatment of transsexual persons: An endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism. 2009;94:3132–3154
  15. Herbst J, Jacobs ED, Finlayson TJ, McKleroy VS, Neumann MS, Crepaz N the HIV/AIDS Prevention Research Synthesis Team &. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: A systematic review. AIDS & Behavior. 2008;12(1):1–17
  16. Hoebeke P, Selvaggi G, Ceulemans P, De Cuypere G, T'Sjoen G, Weyers S, et al. Impact of sex reassignment surgery on lower urinary tract function. European Urology. 2005;47:398–402
  17. Hudson's FTM Resource Guide. (2010). Bathroom use & stand-to-pee (STP) devices. Retrieved from http://www.ftmguide.org/bathroom.html
  18. Jain JK, Paulson RJ. Oocyte preservation. Fertility and Sterility. 2006;86:1037–1046
  19. Kammerer N, Mason T, Connors M, Durkee R. Transgenders, HIV/AIDS, and substance abuse: From risk group to group prevention. In:  Bockting WO,  Kirk S editor. Transgender and HIV: Risks, prevention, and care. New York: Haworth; 2001;p. 13–38
  20. Kaufman R. Introduction to transgender identity and health. In:  Makadon HJ,  Mayer KH,  Potter J,  Goldhammer H editor. Fenway guide to lesbian, gay, bisexual, and transgender health. Philadelphia, PA: Versa; 2008;p. 331–364
  21. Kenagy G, Hsieh CM. The risk less known: Female-to-male transgender persons' vulnerability to HIV infection. AIDS Care. 2005;17(2):195–207
  22. Levy A, Crown A, Reid RW. Endocrine intervention for transsexuals. Clinical Endocrinology. 2003;59(4):409–418
  23. Lombardi EL, Wilchins RA, Priesing D, Malouf D. Gender violence: Transgender experiences with violence and discrimination. Journal of Homosexuality. 2001;42:89–101
  24. Meyer WJ, Bockting WO, Cohen-Kettenis PT, Coleman E, Di Ceglie D, Devor H, et al. The standards of care for gender identity disorders. 6th ed.. Minneapolis, MN: Harry Benjamin International Gender Dysphoria Association; 2001;
  25. Mildvan D, Yarrish R, Marshak A, Hutman HW, McDonough M, Lamson M, et al. Pharmacokinetic interaction between nevirapine and ethinyl estradiol/norethindrone when administered concurrently to HIV-infected women. Journal of Acquired Immune Deficiency Syndromes. 2002;29(5):471–477
  26. Moore E, Wisniewski A, Dobs A. Endocrine treatment of transsexual people: A review of treatment regimens, outcomes, and adverse effects. Journal of Clinical Endocrinology & Metabolism. 2003;88(8):3467–3473
  27. Nelson L, Whallett E, McGregor J. Transgender patient satisfaction following reduction mammaplasty. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2009;62(3):331–334
  28. Nuttbrock L, Hwahng S, Bockting W, Rosenblum A, Mason M, Macri M, et al. Lifetime risk factors for HIV/sexually transmitted infections among male-to female transgender persons. Journal of Acquired Immune Deficiency Syndrome. 2009;52(3):417–421
  29. Oriel KA. Medical care of transsexual patients. Journal of the Gay & Lesbian Medical Association. 2000;4(4):185–194
  30. Ouellet D, Hsu A, Qian J, Locke CS, Eason CJ, Cavanaugh JH, et al. Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers. British Journal of Clinical Pharmacology. 1998;46(2):111–116
  31. Perrone AM, Cerpolini S, Salfi M, Ceccarelli C, De Giorgi LB, Formelli G, et al. Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals. Journal of Sexual Medicine. 2009;6(11):3193–3200
  32. Royal College of Psychiatrists. (2006). Good practice guidelines for the assessment & treatment of gender dysphoria. Retrieved from http://www.rcpsych.ac.uk/pdf/Standards%20of%20Care%20Draft%20v8%203b%20final.pdf
  33. Salazar, C. (2010). Despite risk of death, disfigurement, some get black-market silicone injections. Retrieved from http://www.newser.com/article/d9d5137g2/despite-risk-ofdeath-disfigurement-some-get-black-market-silicone-injections.html
  34. Schroeter CA, Groenewegen JS, Reineke T, Neumann HA. Ninety percent permanent hair reduction in transsexual patients. Annals of Plastic Surgery. 2003;51(3):243–248
  35. Soli M, Brunocilla E, Bertaccini A, Palmieri F, Barbieri B, Martorana G. Male to female gender reassignment: Modified surgical technique for creating the neoclitoris and mons veneris. Journal of Sexual Medicine. 2008;5(1):210–216
  36. Sosa M, Jodar E, Arbelo E, Dominguez C, Saavedra P, Torres A, et al. Serum lipids and estrogen receptor gene polymorphisms in male-to-female transsexuals: Effects of estrogen treatment. European Journal of Internal Medicine. 2004;15(4):231–237
  37. Thomson N, Sutcliffe CG, Sirirojn B, Sintupat K, Aramrattana A, Samuels A, et al. Penile modification in young Thai men: Risk environments, procedures and widespread implications for HIV and sexually transmitted infections. Sexually Transmitted Infections. 2008;84(3):195–197
  38. Tom Waddell Health Center Transgender Team. (2006). Protocols for hormonal reassignment of gender. Retrieved from http://www.sfdph.org/dph/comupg/oservices/medSvs/hlthCtrs/TransGendprotocols12206.pdf
  39. Toorians AW, Thomassen MC, Zweegman S, Magdeleyns EJ, Tans G, Gooren LJ, et al. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. Journal of Clinical Endocrinology & Metabolism. 2003;88(12):5723–5729
  40. van Trotsenburg MA. Gynecological aspects of transgender healthcare. International Journal of Transgenderism. 2009;11(4):238–246
  41. Vancouver Coastal Health, Transcend Transgender Support and Education Society, & the Canadian Rainbow Health Coalition. (2006). Endocrine therapy for transgender adults in British Columbia: Suggested guidelines. Retrieved from http://transhealth.vch.ca/resources/library/tcpdocs/guidelines-endocrine.pdf
  42. Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW. Reducing the risk of sexual HIV transmission: Quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sexually Transmitted Diseases. 2002;29(1):38–43

 Disclosure: This article contains graphic language and content. JANAC's editorial staff understands that HIV infection is related to sexual activities and drug use, and we believe that these topics deserve frank and sometimes-explicit discussions. We are dedicated to preserving the integrity of the HIV-related work of our authors in all areas of concern.

PII: S1055-3290(10)00039-7

doi: 10.1016/j.jana.2010.02.004

Journal of the Association of Nurses in AIDS Care
Volume 21, Issue 3 , Pages 221-229 , May 2010

Article Tools